identification pain questionnaire |
262 |
neuropathic pain |
262 |
outcome measures |
262 |
immunoglobulin g4-related disease |
343 |
mikulicz’s disease |
343 |
thrombocytopenia |
343 |
depression |
274, 253, 245 |
function |
274 |
knee |
274 |
osteoarthritis |
274 |
beighton score |
268 |
hypermobility |
268 |
musculoskeletal |
268 |
prevalence |
268 |
school-age children |
268 |
scoliosis |
268 |
fatigue |
253 |
quality of life |
253, 317 |
systemic scleroderma |
253 |
etiology |
294 |
juvenile idiopathic arthritis |
294 |
pediatrics |
294 |
uveitis |
294 |
anxiety |
245 |
domestic violence |
245 |
fibromyalgia syndrome |
245 |
intimate partner violence |
245 |
pain |
245 |
disease severity |
288 |
familial mediterranean fever |
288, 338 |
growth |
288 |
international severity scoring system for familial mediterranean fever |
288 |
m694v |
288 |
extracorporeal shock wave therapy |
281 |
fibromyalgia |
281 |
rheumatoid arthritis |
281, 334 |
rotator cuff tendinitis |
281 |
angioedema |
301 |
cross-sectional study |
301 |
epidemiology |
301 |
national inpatient sample |
301 |
systemic lupus erythematosus |
301 |
hairy tongue |
348 |
polymyalgia rheumatica |
348 |
prednisolone |
348 |
anti-tumor necrosis factor |
357 |
certolizumab pegol |
357 |
pregnancy |
357 |
takayasu arteritis |
357 |
corticosteroid |
308 |
exercise |
308 |
physical therapy |
308 |
platelet-rich plasma |
308 |
anti-interleukin-1 |
352 |
congenital dyserythropoietic anemia |
352 |
lpin2 mutation |
352 |
majeed syndrome |
352 |
recurrent multifocal osteomyelitis |
352 |
adenosine deaminase 2 deficiency |
338 |
adolescent |
338 |
polyarteritis nodosa |
338 |
antinuclear antibodies |
326 |
autoimmune rheumatic diseases |
326 |
indirect immunofluorescence |
326 |
subjectivity |
326 |
ankylosing spondylitis |
317 |
cardiopulmonary exercise testing |
317 |
pulmonary function test |
317 |
magnetic resonance imaging |
334 |
olfactory bulb volume |
334 |